Drug recall · December 19, 2018
Westminster Irbesartan Tablets recall
Why: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Westminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-119-01; b) 90 count bottle NDC 69367-119-03
- Lots / codes
Batch Numbers: a) B160002A Exp. 09/30/2019; b) B160002B Exp. 09/30/2019
- Quantity
- 1571 bottles
- Company
- Westminster Pharmaceuticals Llc, Olive Branch, MS
- Distribution
- Nationwide.
- Initiated
- October 29, 2018 · Voluntary: Firm initiated
- Classified
- December 14, 2018
- Reported
- December 19, 2018
- Ended
- October 26, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Irbesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.